Back to Top
Brentuximab Vedotin Biosimilar - Research Grade
Add recommended extras
| Concentration | 1mg/ml |
|---|---|
| Isotype | IgG1 |
| Host | CHO Cells |
| Shipping Conditions | Room Temp |
| background | Brentuximab vedotin is an ADC consisting of a CD30-directed antibody and Monomethyl auristatin E (MMAE) that inhibits CD30-positive cells and is used for the study of relapsed and refractory Hogkin's lymphoma. |
| Other names | MMAE |
| Target | TNFRSF8 / CD30 |
| Species Reactivity | Human |
| Formulation | 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) |
| Purity | >90% by SDS-PAGE |
| Storage | This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C. |
| Applications | Functional Assays |
| Application Notes | Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex. |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Delivery Time | 1 week |
Write Your Own Review
Who Viewed This Also Viewed
